117 related articles for article (PubMed ID: 32729728)
1. Formulation of amorphous ternary solid dispersions of dapagliflozin using PEG 6000 and Poloxamer 188: solid-state characterization,
Alruwaili NK; Zafar A; Imam SS; Alharbi KS; Alshehri S; Elsaman T; Alomar FA; Akhtar S; Fahmy UA; Alhakamy NA; Alshammari MS
Drug Dev Ind Pharm; 2020 Sep; 46(9):1458-1467. PubMed ID: 32729728
[TBL] [Abstract][Full Text] [Related]
2. Structural Elucidation of Poloxamer 237 and Poloxamer 237/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution.
Orlandi S; Priotti J; Diogo HP; Leonardi D; Salomon CJ; Nunes TG
AAPS PharmSciTech; 2018 Apr; 19(3):1274-1286. PubMed ID: 29313262
[TBL] [Abstract][Full Text] [Related]
3. Spray-dried solid dispersions containing ferulic acid: comparative analysis of three carriers, in vitro dissolution, antioxidant potential and in vivo anti-platelet effect.
Nadal JM; Gomes ML; Borsato DM; Almeida MA; Barboza FM; Zawadzki SF; Farago PV; Zanin SM
Drug Dev Ind Pharm; 2016 Nov; 42(11):1813-24. PubMed ID: 27032626
[TBL] [Abstract][Full Text] [Related]
4. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions.
Medarević DP; Kachrimanis K; Mitrić M; Djuriš J; Djurić Z; Ibrić S
Pharm Dev Technol; 2016; 21(3):268-76. PubMed ID: 25582577
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
6. Formulation of silymarin binary and ternary solid dispersions: Characterization, simulation study and cell viability assessment against lung cancer cell line.
Alkathiri FA; Bukhari SI; Imam SS; Alshehri S; Mahdi WA
Heliyon; 2024 Jan; 10(1):e23221. PubMed ID: 38163135
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
8. Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers.
Xu WJ; Xie HJ; Cao QR; Shi LL; Cao Y; Zhu XY; Cui JH
Drug Deliv; 2016; 23(1):41-8. PubMed ID: 24735247
[TBL] [Abstract][Full Text] [Related]
9. Investigating the physicochemical properties of solid dispersions based on semicrystalline carriers: A case study with ketoprofen.
Bertoni S; Albertini B; Passerini N
Int J Pharm; 2023 Feb; 632():122576. PubMed ID: 36596317
[TBL] [Abstract][Full Text] [Related]
10. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
11. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
Thenmozhi K; Yoo YJ
Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
[TBL] [Abstract][Full Text] [Related]
12. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
[TBL] [Abstract][Full Text] [Related]
14. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.
Goddeeris C; Van den Mooter G
Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442
[TBL] [Abstract][Full Text] [Related]
15. Preparation and Characterization of Solid Dispersions of Artemether by Freeze-Dried Method.
Ansari MT; Hussain A; Nadeem S; Majeed H; Saeed-Ul-Hassan S; Tariq I; Mahmood Q; Khan AK; Murtaza G
Biomed Res Int; 2015; 2015():109563. PubMed ID: 26097842
[TBL] [Abstract][Full Text] [Related]
16. Dissolution and oral bioavailability enhancement of praziquantel by solid dispersions.
Liu Y; Wang T; Ding W; Dong C; Wang X; Chen J; Li Y
Drug Deliv Transl Res; 2018 Jun; 8(3):580-590. PubMed ID: 29450806
[TBL] [Abstract][Full Text] [Related]
17. Development and in vitro evaluation of solid dispersions as strategy to improve albendazole biopharmaceutical behavior.
Simonazzi A; Cid AG; Paredes AJ; Schofs L; Gonzo EE; Palma SD; Bermúdez JM
Ther Deliv; 2018 Sep; 9(9):623-638. PubMed ID: 30189808
[TBL] [Abstract][Full Text] [Related]
18. Solubility enhancement of desloratadine by solid dispersion in poloxamers.
Kolašinac N; Kachrimanis K; Homšek I; Grujić B; Ðurić Z; Ibrić S
Int J Pharm; 2012 Oct; 436(1-2):161-70. PubMed ID: 22772487
[TBL] [Abstract][Full Text] [Related]
19. Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design.
Djuris J; Ioannis N; Ibric S; Djuric Z; Kachrimanis K
J Pharm Pharmacol; 2014 Feb; 66(2):232-43. PubMed ID: 24350884
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of domperidone solid dispersions.
Essa EA; Balata GF
Pak J Pharm Sci; 2012 Oct; 25(4):783-91. PubMed ID: 23009995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
